Enzymotec (NASDAQ: ENZY) and Westlake Chemical (NYSE:WLK) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.


This table compares Enzymotec and Westlake Chemical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Enzymotec -12.32% -3.26% -2.99%
Westlake Chemical 7.74% 15.59% 5.95%

Institutional & Insider Ownership

15.7% of Enzymotec shares are owned by institutional investors. Comparatively, 30.4% of Westlake Chemical shares are owned by institutional investors. 71.7% of Westlake Chemical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Enzymotec and Westlake Chemical, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enzymotec 0 2 0 0 2.00
Westlake Chemical 0 2 10 0 2.83

Enzymotec presently has a consensus target price of $11.75, indicating a potential downside of 0.84%. Westlake Chemical has a consensus target price of $103.80, indicating a potential upside of 0.46%. Given Westlake Chemical’s stronger consensus rating and higher probable upside, analysts clearly believe Westlake Chemical is more favorable than Enzymotec.

Volatility & Risk

Enzymotec has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Comparatively, Westlake Chemical has a beta of 1.71, meaning that its stock price is 71% more volatile than the S&P 500.


Westlake Chemical pays an annual dividend of $0.84 per share and has a dividend yield of 0.8%. Enzymotec does not pay a dividend. Westlake Chemical pays out 18.3% of its earnings in the form of a dividend. Enzymotec has increased its dividend for 13 consecutive years.

Earnings & Valuation

This table compares Enzymotec and Westlake Chemical’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Enzymotec $47.70 million 5.82 -$2.92 million ($0.26) -45.58
Westlake Chemical $5.08 billion 2.63 $398.85 million $4.60 22.46

Westlake Chemical has higher revenue and earnings than Enzymotec. Enzymotec is trading at a lower price-to-earnings ratio than Westlake Chemical, indicating that it is currently the more affordable of the two stocks.


Westlake Chemical beats Enzymotec on 13 of the 16 factors compared between the two stocks.

About Enzymotec

Enzymotec Ltd. is a nutritional ingredients and medical foods company. The Company’s technologies, research expertise and clinical validation process enables it to develop solutions across a range of products. The Company operates in two segments: Nutrition segment and VAYA Pharma segment. Both of the Company’s segments offer a range of products that leverage its lipid-related offerings. Its product suite addresses the entire human life-cycle, from infancy to old age, and comprises ingredients in products ranging from infant formula to nutritional supplements, as well as branded medical foods, sold only under a doctor’s supervision. It markets its product portfolio to established global consumer companies and physicians and target large and growing consumer health and wellness markets. The Company’s clinically-validated products include bio-functional lipid-based compounds designed to address dietary needs, medical disorders and common diseases.

About Westlake Chemical

Westlake Chemical Corporation is a global manufacturer and marketer of basic chemicals, vinyls, polymers and building products. The Company’s products include a range of chemicals, which are fundamental to various consumer and industrial markets, including flexible and rigid packaging, automotive products, coatings, water treatment, refrigerants, residential and commercial construction, as well as other durable and non-durable goods. Its segments include Olefins and Vinyls. It manufactures ethylene (through Westlake Chemical OpCo LP (OpCo)), polyethylene, styrene and associated co-products at its manufacturing facility in Lake Charles and polyethylene at its Longview facility. The Company’s products in its Vinyls segment include polyvinyl chloride (PVC), vinyl chloride monomer (VCM), ethylene dichloride (EDC), chlor-alkali (chlorine and caustic soda) and chlorinated derivative products and, through OpCo, ethylene. It also manufactures and sells building products fabricated from PVC.

Receive News & Ratings for Enzymotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzymotec and related companies with MarketBeat.com's FREE daily email newsletter.